Global Liraglutide Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Liraglutide market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
United States market for Liraglutide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Liraglutide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Liraglutide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Liraglutide players cover HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Liraglutide Industry Forecast” looks at past sales and reviews total world Liraglutide sales in 2024, providing a comprehensive analysis by region and market sector of projected Liraglutide sales for 2025 through 2031. With Liraglutide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liraglutide industry.
This Insight Report provides a comprehensive analysis of the global Liraglutide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liraglutide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liraglutide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liraglutide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liraglutide.
This report presents a comprehensive overview, market shares, and growth opportunities of Liraglutide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Liraglutide market?
What factors are driving Liraglutide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liraglutide market opportunities vary by end market size?
How does Liraglutide break out by Type, by Application?
The global Liraglutide market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
United States market for Liraglutide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Liraglutide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Liraglutide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Liraglutide players cover HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Liraglutide Industry Forecast” looks at past sales and reviews total world Liraglutide sales in 2024, providing a comprehensive analysis by region and market sector of projected Liraglutide sales for 2025 through 2031. With Liraglutide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liraglutide industry.
This Insight Report provides a comprehensive analysis of the global Liraglutide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liraglutide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liraglutide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liraglutide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liraglutide.
This report presents a comprehensive overview, market shares, and growth opportunities of Liraglutide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pills
- Liquid
- Hospital
- Drug Store
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- HEC Pharm
- Bachem
- Bharat Pharmaceuticals
- Kingpep Biotechnology
- Shenzhen JYMed Technology
- Wuxi Asiapeptide
- AmbioPharm
What is the 10-year outlook for the global Liraglutide market?
What factors are driving Liraglutide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liraglutide market opportunities vary by end market size?
How does Liraglutide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liraglutide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Liraglutide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Liraglutide by Country/Region, 2020, 2024 & 2031
2.2 Liraglutide Segment by Type
2.2.1 Pills
2.2.2 Liquid
2.3 Liraglutide Sales by Type
2.3.1 Global Liraglutide Sales Market Share by Type (2020-2025)
2.3.2 Global Liraglutide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Liraglutide Sale Price by Type (2020-2025)
2.4 Liraglutide Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.5 Liraglutide Sales by Application
2.5.1 Global Liraglutide Sale Market Share by Application (2020-2025)
2.5.2 Global Liraglutide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Liraglutide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Liraglutide Breakdown Data by Company
3.1.1 Global Liraglutide Annual Sales by Company (2020-2025)
3.1.2 Global Liraglutide Sales Market Share by Company (2020-2025)
3.2 Global Liraglutide Annual Revenue by Company (2020-2025)
3.2.1 Global Liraglutide Revenue by Company (2020-2025)
3.2.2 Global Liraglutide Revenue Market Share by Company (2020-2025)
3.3 Global Liraglutide Sale Price by Company
3.4 Key Manufacturers Liraglutide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liraglutide Product Location Distribution
3.4.2 Players Liraglutide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIRAGLUTIDE BY GEOGRAPHIC REGION
4.1 World Historic Liraglutide Market Size by Geographic Region (2020-2025)
4.1.1 Global Liraglutide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Liraglutide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Liraglutide Market Size by Country/Region (2020-2025)
4.2.1 Global Liraglutide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Liraglutide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liraglutide Sales Growth
4.4 APAC Liraglutide Sales Growth
4.5 Europe Liraglutide Sales Growth
4.6 Middle East & Africa Liraglutide Sales Growth
5 AMERICAS
5.1 Americas Liraglutide Sales by Country
5.1.1 Americas Liraglutide Sales by Country (2020-2025)
5.1.2 Americas Liraglutide Revenue by Country (2020-2025)
5.2 Americas Liraglutide Sales by Type (2020-2025)
5.3 Americas Liraglutide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liraglutide Sales by Region
6.1.1 APAC Liraglutide Sales by Region (2020-2025)
6.1.2 APAC Liraglutide Revenue by Region (2020-2025)
6.2 APAC Liraglutide Sales by Type (2020-2025)
6.3 APAC Liraglutide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Liraglutide by Country
7.1.1 Europe Liraglutide Sales by Country (2020-2025)
7.1.2 Europe Liraglutide Revenue by Country (2020-2025)
7.2 Europe Liraglutide Sales by Type (2020-2025)
7.3 Europe Liraglutide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liraglutide by Country
8.1.1 Middle East & Africa Liraglutide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Liraglutide Revenue by Country (2020-2025)
8.2 Middle East & Africa Liraglutide Sales by Type (2020-2025)
8.3 Middle East & Africa Liraglutide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liraglutide
10.3 Manufacturing Process Analysis of Liraglutide
10.4 Industry Chain Structure of Liraglutide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liraglutide Distributors
11.3 Liraglutide Customer
12 WORLD FORECAST REVIEW FOR LIRAGLUTIDE BY GEOGRAPHIC REGION
12.1 Global Liraglutide Market Size Forecast by Region
12.1.1 Global Liraglutide Forecast by Region (2026-2031)
12.1.2 Global Liraglutide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Liraglutide Forecast by Type (2026-2031)
12.7 Global Liraglutide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 HEC Pharm
13.1.1 HEC Pharm Company Information
13.1.2 HEC Pharm Liraglutide Product Portfolios and Specifications
13.1.3 HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 HEC Pharm Main Business Overview
13.1.5 HEC Pharm Latest Developments
13.2 Bachem
13.2.1 Bachem Company Information
13.2.2 Bachem Liraglutide Product Portfolios and Specifications
13.2.3 Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bachem Main Business Overview
13.2.5 Bachem Latest Developments
13.3 Bharat Pharmaceuticals
13.3.1 Bharat Pharmaceuticals Company Information
13.3.2 Bharat Pharmaceuticals Liraglutide Product Portfolios and Specifications
13.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bharat Pharmaceuticals Main Business Overview
13.3.5 Bharat Pharmaceuticals Latest Developments
13.4 Kingpep Biotechnology
13.4.1 Kingpep Biotechnology Company Information
13.4.2 Kingpep Biotechnology Liraglutide Product Portfolios and Specifications
13.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Kingpep Biotechnology Main Business Overview
13.4.5 Kingpep Biotechnology Latest Developments
13.5 Shenzhen JYMed Technology
13.5.1 Shenzhen JYMed Technology Company Information
13.5.2 Shenzhen JYMed Technology Liraglutide Product Portfolios and Specifications
13.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shenzhen JYMed Technology Main Business Overview
13.5.5 Shenzhen JYMed Technology Latest Developments
13.6 Wuxi Asiapeptide
13.6.1 Wuxi Asiapeptide Company Information
13.6.2 Wuxi Asiapeptide Liraglutide Product Portfolios and Specifications
13.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Wuxi Asiapeptide Main Business Overview
13.6.5 Wuxi Asiapeptide Latest Developments
13.7 AmbioPharm
13.7.1 AmbioPharm Company Information
13.7.2 AmbioPharm Liraglutide Product Portfolios and Specifications
13.7.3 AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 AmbioPharm Main Business Overview
13.7.5 AmbioPharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Liraglutide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Liraglutide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pills
Table 4. Major Players of Liquid
Table 5. Global Liraglutide Sales byType (2020-2025) & (K MT)
Table 6. Global Liraglutide Sales Market Share byType (2020-2025)
Table 7. Global Liraglutide Revenue byType (2020-2025) & ($ million)
Table 8. Global Liraglutide Revenue Market Share byType (2020-2025)
Table 9. Global Liraglutide Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Liraglutide Sale by Application (2020-2025) & (K MT)
Table 11. Global Liraglutide Sale Market Share by Application (2020-2025)
Table 12. Global Liraglutide Revenue by Application (2020-2025) & ($ million)
Table 13. Global Liraglutide Revenue Market Share by Application (2020-2025)
Table 14. Global Liraglutide Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Liraglutide Sales by Company (2020-2025) & (K MT)
Table 16. Global Liraglutide Sales Market Share by Company (2020-2025)
Table 17. Global Liraglutide Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Liraglutide Revenue Market Share by Company (2020-2025)
Table 19. Global Liraglutide Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Liraglutide Producing Area Distribution and Sales Area
Table 21. Players Liraglutide Products Offered
Table 22. Liraglutide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Liraglutide Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Liraglutide Sales Market Share Geographic Region (2020-2025)
Table 27. Global Liraglutide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Liraglutide Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Liraglutide Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Liraglutide Sales Market Share by Country/Region (2020-2025)
Table 31. Global Liraglutide Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Liraglutide Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Liraglutide Sales by Country (2020-2025) & (K MT)
Table 34. Americas Liraglutide Sales Market Share by Country (2020-2025)
Table 35. Americas Liraglutide Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Liraglutide Sales byType (2020-2025) & (K MT)
Table 37. Americas Liraglutide Sales by Application (2020-2025) & (K MT)
Table 38. APAC Liraglutide Sales by Region (2020-2025) & (K MT)
Table 39. APAC Liraglutide Sales Market Share by Region (2020-2025)
Table 40. APAC Liraglutide Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Liraglutide Sales byType (2020-2025) & (K MT)
Table 42. APAC Liraglutide Sales by Application (2020-2025) & (K MT)
Table 43. Europe Liraglutide Sales by Country (2020-2025) & (K MT)
Table 44. Europe Liraglutide Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Liraglutide Sales byType (2020-2025) & (K MT)
Table 46. Europe Liraglutide Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Liraglutide Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Liraglutide Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Liraglutide Sales byType (2020-2025) & (K MT)
Table 50. Middle East & Africa Liraglutide Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Liraglutide
Table 52. Key Market Challenges & Risks of Liraglutide
Table 53. Key IndustryTrends of Liraglutide
Table 54. Liraglutide Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Liraglutide Distributors List
Table 57. Liraglutide Customer List
Table 58. Global Liraglutide SalesForecast by Region (2026-2031) & (K MT)
Table 59. Global Liraglutide RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Liraglutide SalesForecast by Country (2026-2031) & (K MT)
Table 61. Americas Liraglutide Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Liraglutide SalesForecast by Region (2026-2031) & (K MT)
Table 63. APAC Liraglutide Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Liraglutide SalesForecast by Country (2026-2031) & (K MT)
Table 65. Europe Liraglutide RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Liraglutide SalesForecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Liraglutide RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Liraglutide SalesForecast byType (2026-2031) & (K MT)
Table 69. Global Liraglutide RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Liraglutide SalesForecast by Application (2026-2031) & (K MT)
Table 71. Global Liraglutide RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. HEC Pharm Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 73. HEC Pharm Liraglutide Product Portfolios and Specifications
Table 74. HEC Pharm Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. HEC Pharm Main Business
Table 76. HEC Pharm Latest Developments
Table 77. Bachem Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 78. Bachem Liraglutide Product Portfolios and Specifications
Table 79. Bachem Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Bachem Main Business
Table 81. Bachem Latest Developments
Table 82. Bharat Pharmaceuticals Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 83. Bharat Pharmaceuticals Liraglutide Product Portfolios and Specifications
Table 84. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Bharat Pharmaceuticals Main Business
Table 86. Bharat Pharmaceuticals Latest Developments
Table 87. Kingpep Biotechnology Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 88. Kingpep Biotechnology Liraglutide Product Portfolios and Specifications
Table 89. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Kingpep Biotechnology Main Business
Table 91. Kingpep Biotechnology Latest Developments
Table 92. Shenzhen JYMedTechnology Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 93. Shenzhen JYMedTechnology Liraglutide Product Portfolios and Specifications
Table 94. Shenzhen JYMedTechnology Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Shenzhen JYMedTechnology Main Business
Table 96. Shenzhen JYMedTechnology Latest Developments
Table 97. Wuxi Asiapeptide Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 98. Wuxi Asiapeptide Liraglutide Product Portfolios and Specifications
Table 99. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Wuxi Asiapeptide Main Business
Table 101. Wuxi Asiapeptide Latest Developments
Table 102. AmbioPharm Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 103. AmbioPharm Liraglutide Product Portfolios and Specifications
Table 104. AmbioPharm Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. AmbioPharm Main Business
Table 106. AmbioPharm Latest Developments
LIST OFFIGURES
Figure 1. Picture of Liraglutide
Figure 2. Liraglutide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liraglutide Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Liraglutide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Liraglutide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Liraglutide Sales Market Share by Country/Region (2024)
Figure 10. Liraglutide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pills
Figure 12. Product Picture of Liquid
Figure 13. Global Liraglutide Sales Market Share byType in 2025
Figure 14. Global Liraglutide Revenue Market Share byType (2020-2025)
Figure 15. Liraglutide Consumed in Hospital
Figure 16. Global Liraglutide Market: Hospital (2020-2025) & (K MT)
Figure 17. Liraglutide Consumed in Drug Store
Figure 18. Global Liraglutide Market: Drug Store (2020-2025) & (K MT)
Figure 19. Global Liraglutide Sale Market Share by Application (2024)
Figure 20. Global Liraglutide Revenue Market Share by Application in 2025
Figure 21. Liraglutide Sales by Company in 2025 (K MT)
Figure 22. Global Liraglutide Sales Market Share by Company in 2025
Figure 23. Liraglutide Revenue by Company in 2025 ($ millions)
Figure 24. Global Liraglutide Revenue Market Share by Company in 2025
Figure 25. Global Liraglutide Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Liraglutide Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Liraglutide Sales 2020-2025 (K MT)
Figure 28. Americas Liraglutide Revenue 2020-2025 ($ millions)
Figure 29. APAC Liraglutide Sales 2020-2025 (K MT)
Figure 30. APAC Liraglutide Revenue 2020-2025 ($ millions)
Figure 31. Europe Liraglutide Sales 2020-2025 (K MT)
Figure 32. Europe Liraglutide Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Liraglutide Sales 2020-2025 (K MT)
Figure 34. Middle East & Africa Liraglutide Revenue 2020-2025 ($ millions)
Figure 35. Americas Liraglutide Sales Market Share by Country in 2025
Figure 36. Americas Liraglutide Revenue Market Share by Country (2020-2025)
Figure 37. Americas Liraglutide Sales Market Share byType (2020-2025)
Figure 38. Americas Liraglutide Sales Market Share by Application (2020-2025)
Figure 39. United States Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Liraglutide Sales Market Share by Region in 2025
Figure 44. APAC Liraglutide Revenue Market Share by Region (2020-2025)
Figure 45. APAC Liraglutide Sales Market Share byType (2020-2025)
Figure 46. APAC Liraglutide Sales Market Share by Application (2020-2025)
Figure 47. China Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 51. India Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Liraglutide Sales Market Share by Country in 2025
Figure 55. Europe Liraglutide Revenue Market Share by Country (2020-2025)
Figure 56. Europe Liraglutide Sales Market Share byType (2020-2025)
Figure 57. Europe Liraglutide Sales Market Share by Application (2020-2025)
Figure 58. Germany Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 59.France Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Liraglutide Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Liraglutide Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Liraglutide Sales Market Share by Application (2020-2025)
Figure 66. Egypt Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Liraglutide in 2025
Figure 72. Manufacturing Process Analysis of Liraglutide
Figure 73. Industry Chain Structure of Liraglutide
Figure 74. Channels of Distribution
Figure 75. Global Liraglutide Sales MarketForecast by Region (2026-2031)
Figure 76. Global Liraglutide Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Liraglutide Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Liraglutide Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Liraglutide Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Liraglutide Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liraglutide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Liraglutide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Liraglutide by Country/Region, 2020, 2024 & 2031
2.2 Liraglutide Segment by Type
2.2.1 Pills
2.2.2 Liquid
2.3 Liraglutide Sales by Type
2.3.1 Global Liraglutide Sales Market Share by Type (2020-2025)
2.3.2 Global Liraglutide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Liraglutide Sale Price by Type (2020-2025)
2.4 Liraglutide Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.5 Liraglutide Sales by Application
2.5.1 Global Liraglutide Sale Market Share by Application (2020-2025)
2.5.2 Global Liraglutide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Liraglutide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Liraglutide Breakdown Data by Company
3.1.1 Global Liraglutide Annual Sales by Company (2020-2025)
3.1.2 Global Liraglutide Sales Market Share by Company (2020-2025)
3.2 Global Liraglutide Annual Revenue by Company (2020-2025)
3.2.1 Global Liraglutide Revenue by Company (2020-2025)
3.2.2 Global Liraglutide Revenue Market Share by Company (2020-2025)
3.3 Global Liraglutide Sale Price by Company
3.4 Key Manufacturers Liraglutide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liraglutide Product Location Distribution
3.4.2 Players Liraglutide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIRAGLUTIDE BY GEOGRAPHIC REGION
4.1 World Historic Liraglutide Market Size by Geographic Region (2020-2025)
4.1.1 Global Liraglutide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Liraglutide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Liraglutide Market Size by Country/Region (2020-2025)
4.2.1 Global Liraglutide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Liraglutide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liraglutide Sales Growth
4.4 APAC Liraglutide Sales Growth
4.5 Europe Liraglutide Sales Growth
4.6 Middle East & Africa Liraglutide Sales Growth
5 AMERICAS
5.1 Americas Liraglutide Sales by Country
5.1.1 Americas Liraglutide Sales by Country (2020-2025)
5.1.2 Americas Liraglutide Revenue by Country (2020-2025)
5.2 Americas Liraglutide Sales by Type (2020-2025)
5.3 Americas Liraglutide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liraglutide Sales by Region
6.1.1 APAC Liraglutide Sales by Region (2020-2025)
6.1.2 APAC Liraglutide Revenue by Region (2020-2025)
6.2 APAC Liraglutide Sales by Type (2020-2025)
6.3 APAC Liraglutide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Liraglutide by Country
7.1.1 Europe Liraglutide Sales by Country (2020-2025)
7.1.2 Europe Liraglutide Revenue by Country (2020-2025)
7.2 Europe Liraglutide Sales by Type (2020-2025)
7.3 Europe Liraglutide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liraglutide by Country
8.1.1 Middle East & Africa Liraglutide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Liraglutide Revenue by Country (2020-2025)
8.2 Middle East & Africa Liraglutide Sales by Type (2020-2025)
8.3 Middle East & Africa Liraglutide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liraglutide
10.3 Manufacturing Process Analysis of Liraglutide
10.4 Industry Chain Structure of Liraglutide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liraglutide Distributors
11.3 Liraglutide Customer
12 WORLD FORECAST REVIEW FOR LIRAGLUTIDE BY GEOGRAPHIC REGION
12.1 Global Liraglutide Market Size Forecast by Region
12.1.1 Global Liraglutide Forecast by Region (2026-2031)
12.1.2 Global Liraglutide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Liraglutide Forecast by Type (2026-2031)
12.7 Global Liraglutide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 HEC Pharm
13.1.1 HEC Pharm Company Information
13.1.2 HEC Pharm Liraglutide Product Portfolios and Specifications
13.1.3 HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 HEC Pharm Main Business Overview
13.1.5 HEC Pharm Latest Developments
13.2 Bachem
13.2.1 Bachem Company Information
13.2.2 Bachem Liraglutide Product Portfolios and Specifications
13.2.3 Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bachem Main Business Overview
13.2.5 Bachem Latest Developments
13.3 Bharat Pharmaceuticals
13.3.1 Bharat Pharmaceuticals Company Information
13.3.2 Bharat Pharmaceuticals Liraglutide Product Portfolios and Specifications
13.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bharat Pharmaceuticals Main Business Overview
13.3.5 Bharat Pharmaceuticals Latest Developments
13.4 Kingpep Biotechnology
13.4.1 Kingpep Biotechnology Company Information
13.4.2 Kingpep Biotechnology Liraglutide Product Portfolios and Specifications
13.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Kingpep Biotechnology Main Business Overview
13.4.5 Kingpep Biotechnology Latest Developments
13.5 Shenzhen JYMed Technology
13.5.1 Shenzhen JYMed Technology Company Information
13.5.2 Shenzhen JYMed Technology Liraglutide Product Portfolios and Specifications
13.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shenzhen JYMed Technology Main Business Overview
13.5.5 Shenzhen JYMed Technology Latest Developments
13.6 Wuxi Asiapeptide
13.6.1 Wuxi Asiapeptide Company Information
13.6.2 Wuxi Asiapeptide Liraglutide Product Portfolios and Specifications
13.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Wuxi Asiapeptide Main Business Overview
13.6.5 Wuxi Asiapeptide Latest Developments
13.7 AmbioPharm
13.7.1 AmbioPharm Company Information
13.7.2 AmbioPharm Liraglutide Product Portfolios and Specifications
13.7.3 AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 AmbioPharm Main Business Overview
13.7.5 AmbioPharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Liraglutide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Liraglutide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pills
Table 4. Major Players of Liquid
Table 5. Global Liraglutide Sales byType (2020-2025) & (K MT)
Table 6. Global Liraglutide Sales Market Share byType (2020-2025)
Table 7. Global Liraglutide Revenue byType (2020-2025) & ($ million)
Table 8. Global Liraglutide Revenue Market Share byType (2020-2025)
Table 9. Global Liraglutide Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Liraglutide Sale by Application (2020-2025) & (K MT)
Table 11. Global Liraglutide Sale Market Share by Application (2020-2025)
Table 12. Global Liraglutide Revenue by Application (2020-2025) & ($ million)
Table 13. Global Liraglutide Revenue Market Share by Application (2020-2025)
Table 14. Global Liraglutide Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Liraglutide Sales by Company (2020-2025) & (K MT)
Table 16. Global Liraglutide Sales Market Share by Company (2020-2025)
Table 17. Global Liraglutide Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Liraglutide Revenue Market Share by Company (2020-2025)
Table 19. Global Liraglutide Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Liraglutide Producing Area Distribution and Sales Area
Table 21. Players Liraglutide Products Offered
Table 22. Liraglutide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Liraglutide Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Liraglutide Sales Market Share Geographic Region (2020-2025)
Table 27. Global Liraglutide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Liraglutide Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Liraglutide Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Liraglutide Sales Market Share by Country/Region (2020-2025)
Table 31. Global Liraglutide Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Liraglutide Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Liraglutide Sales by Country (2020-2025) & (K MT)
Table 34. Americas Liraglutide Sales Market Share by Country (2020-2025)
Table 35. Americas Liraglutide Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Liraglutide Sales byType (2020-2025) & (K MT)
Table 37. Americas Liraglutide Sales by Application (2020-2025) & (K MT)
Table 38. APAC Liraglutide Sales by Region (2020-2025) & (K MT)
Table 39. APAC Liraglutide Sales Market Share by Region (2020-2025)
Table 40. APAC Liraglutide Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Liraglutide Sales byType (2020-2025) & (K MT)
Table 42. APAC Liraglutide Sales by Application (2020-2025) & (K MT)
Table 43. Europe Liraglutide Sales by Country (2020-2025) & (K MT)
Table 44. Europe Liraglutide Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Liraglutide Sales byType (2020-2025) & (K MT)
Table 46. Europe Liraglutide Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Liraglutide Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Liraglutide Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Liraglutide Sales byType (2020-2025) & (K MT)
Table 50. Middle East & Africa Liraglutide Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Liraglutide
Table 52. Key Market Challenges & Risks of Liraglutide
Table 53. Key IndustryTrends of Liraglutide
Table 54. Liraglutide Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Liraglutide Distributors List
Table 57. Liraglutide Customer List
Table 58. Global Liraglutide SalesForecast by Region (2026-2031) & (K MT)
Table 59. Global Liraglutide RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Liraglutide SalesForecast by Country (2026-2031) & (K MT)
Table 61. Americas Liraglutide Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Liraglutide SalesForecast by Region (2026-2031) & (K MT)
Table 63. APAC Liraglutide Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Liraglutide SalesForecast by Country (2026-2031) & (K MT)
Table 65. Europe Liraglutide RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Liraglutide SalesForecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Liraglutide RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Liraglutide SalesForecast byType (2026-2031) & (K MT)
Table 69. Global Liraglutide RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Liraglutide SalesForecast by Application (2026-2031) & (K MT)
Table 71. Global Liraglutide RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. HEC Pharm Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 73. HEC Pharm Liraglutide Product Portfolios and Specifications
Table 74. HEC Pharm Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. HEC Pharm Main Business
Table 76. HEC Pharm Latest Developments
Table 77. Bachem Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 78. Bachem Liraglutide Product Portfolios and Specifications
Table 79. Bachem Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Bachem Main Business
Table 81. Bachem Latest Developments
Table 82. Bharat Pharmaceuticals Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 83. Bharat Pharmaceuticals Liraglutide Product Portfolios and Specifications
Table 84. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Bharat Pharmaceuticals Main Business
Table 86. Bharat Pharmaceuticals Latest Developments
Table 87. Kingpep Biotechnology Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 88. Kingpep Biotechnology Liraglutide Product Portfolios and Specifications
Table 89. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Kingpep Biotechnology Main Business
Table 91. Kingpep Biotechnology Latest Developments
Table 92. Shenzhen JYMedTechnology Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 93. Shenzhen JYMedTechnology Liraglutide Product Portfolios and Specifications
Table 94. Shenzhen JYMedTechnology Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Shenzhen JYMedTechnology Main Business
Table 96. Shenzhen JYMedTechnology Latest Developments
Table 97. Wuxi Asiapeptide Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 98. Wuxi Asiapeptide Liraglutide Product Portfolios and Specifications
Table 99. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Wuxi Asiapeptide Main Business
Table 101. Wuxi Asiapeptide Latest Developments
Table 102. AmbioPharm Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 103. AmbioPharm Liraglutide Product Portfolios and Specifications
Table 104. AmbioPharm Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. AmbioPharm Main Business
Table 106. AmbioPharm Latest Developments
LIST OFFIGURES
Figure 1. Picture of Liraglutide
Figure 2. Liraglutide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liraglutide Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Liraglutide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Liraglutide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Liraglutide Sales Market Share by Country/Region (2024)
Figure 10. Liraglutide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pills
Figure 12. Product Picture of Liquid
Figure 13. Global Liraglutide Sales Market Share byType in 2025
Figure 14. Global Liraglutide Revenue Market Share byType (2020-2025)
Figure 15. Liraglutide Consumed in Hospital
Figure 16. Global Liraglutide Market: Hospital (2020-2025) & (K MT)
Figure 17. Liraglutide Consumed in Drug Store
Figure 18. Global Liraglutide Market: Drug Store (2020-2025) & (K MT)
Figure 19. Global Liraglutide Sale Market Share by Application (2024)
Figure 20. Global Liraglutide Revenue Market Share by Application in 2025
Figure 21. Liraglutide Sales by Company in 2025 (K MT)
Figure 22. Global Liraglutide Sales Market Share by Company in 2025
Figure 23. Liraglutide Revenue by Company in 2025 ($ millions)
Figure 24. Global Liraglutide Revenue Market Share by Company in 2025
Figure 25. Global Liraglutide Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Liraglutide Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Liraglutide Sales 2020-2025 (K MT)
Figure 28. Americas Liraglutide Revenue 2020-2025 ($ millions)
Figure 29. APAC Liraglutide Sales 2020-2025 (K MT)
Figure 30. APAC Liraglutide Revenue 2020-2025 ($ millions)
Figure 31. Europe Liraglutide Sales 2020-2025 (K MT)
Figure 32. Europe Liraglutide Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Liraglutide Sales 2020-2025 (K MT)
Figure 34. Middle East & Africa Liraglutide Revenue 2020-2025 ($ millions)
Figure 35. Americas Liraglutide Sales Market Share by Country in 2025
Figure 36. Americas Liraglutide Revenue Market Share by Country (2020-2025)
Figure 37. Americas Liraglutide Sales Market Share byType (2020-2025)
Figure 38. Americas Liraglutide Sales Market Share by Application (2020-2025)
Figure 39. United States Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Liraglutide Sales Market Share by Region in 2025
Figure 44. APAC Liraglutide Revenue Market Share by Region (2020-2025)
Figure 45. APAC Liraglutide Sales Market Share byType (2020-2025)
Figure 46. APAC Liraglutide Sales Market Share by Application (2020-2025)
Figure 47. China Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 51. India Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Liraglutide Sales Market Share by Country in 2025
Figure 55. Europe Liraglutide Revenue Market Share by Country (2020-2025)
Figure 56. Europe Liraglutide Sales Market Share byType (2020-2025)
Figure 57. Europe Liraglutide Sales Market Share by Application (2020-2025)
Figure 58. Germany Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 59.France Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Liraglutide Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Liraglutide Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Liraglutide Sales Market Share by Application (2020-2025)
Figure 66. Egypt Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Liraglutide Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Liraglutide in 2025
Figure 72. Manufacturing Process Analysis of Liraglutide
Figure 73. Industry Chain Structure of Liraglutide
Figure 74. Channels of Distribution
Figure 75. Global Liraglutide Sales MarketForecast by Region (2026-2031)
Figure 76. Global Liraglutide Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Liraglutide Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Liraglutide Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Liraglutide Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Liraglutide Revenue Market ShareForecast by Application (2026-2031)
